within Pharmacolibrary.Drugs.ATC.G;

model G03FA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 30 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>The fixed-dose combination of progesterone and estrogen (with ATC code G03FA04) is used in hormone replacement therapy, particularly for menopausal symptoms such as hot flashes and osteoporosis prevention. It is an approved medication in several countries and is mostly administered orally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated for a typical healthy adult female population receiving oral administration, as no published studies have specifically reported full model parameters for this fixed combination.</p><h4>References</h4><ol><li><p>Sitruk-Ware, R, et al., &amp; Mauvais-Jarvis, P (1987). Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review. <i>Contraception</i> 36(4) 373–402. DOI:<a href=&quot;https://doi.org/10.1016/0010-7824(87)90088-6&quot;>10.1016/0010-7824(87)90088-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3327648/&quot;>https://pubmed.ncbi.nlm.nih.gov/3327648</a></p></li><li><p>Anderson, GD, &amp; Odegard, PS (2004). Pharmacokinetics of estrogen and progesterone in chronic kidney disease. <i>Advances in chronic kidney disease</i> 11(4) 357–360. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15492972/&quot;>https://pubmed.ncbi.nlm.nih.gov/15492972</a></p></li><li><p>Xu, Y, et al., &amp; Cao, Y (2022). Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women. <i>Frontiers in pharmacology</i> 13 1027648–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2022.1027648&quot;>10.3389/fphar.2022.1027648</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36506562/&quot;>https://pubmed.ncbi.nlm.nih.gov/36506562</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03FA04;
